Home › Companies › INARI MEDICAL INC. › 2023-2024

INARI MEDICAL INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and INARI MEDICAL INC.’s Form 8-K, filed 2024-04-25 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 6Ballot items
  • 309Asset managers
  • 2,573Fund votes
  • 2024-04-24Meeting date

Proxy season: 2023-2024

Explore INARI MEDICAL INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by INARI MEDICAL INC.

These tallies are INARI MEDICAL INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-04-25 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

INARI MEDICAL INC. — official shareholder meeting results, meeting held 2024-04-24
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Rebecca Chambers 37,413,521---- 9,684,1986,045,772 Majority: yes
Elect Director: William Hoffman 33,808,366---- 12,904,0666,431,059 Majority: yes
Elect Director: Andrew Hykes 37,514,003---- 9,583,7166,045,772 Majority: yes
Elect Director: Donald Milder 34,564,964---- 12,532,7556,045,772 Majority: yes
Proposal 2: The stockholders ratified the selection of BDO USA, PC as the Company's independent registered public accounting firm for the year ending December 31, 2024. 53,055,76838,76148,962 --0 Majority: yes
Proposal 3: The stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in our proxy statement. 44,404,4872,164,720546,058 --6,028,226 Majority: yes

Source: INARI MEDICAL INC., Form 8-K, filed with the SEC on 2024-04-25 — read the filing on EDGAR.

How asset managers voted at the INARI MEDICAL INC. 2023-2024 meeting

Each item below shows how the 309 asset managers that disclosed a INARI MEDICAL INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To approve, on an advisory basis, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 11 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 44,404,487AGAINST: 2,164,720

INARI MEDICAL INC.’s own tally for this item (“Proposal 3: The stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in our proxy statement.”): 44,404,487 for, 2,164,720 against, per its Form 8-K filed 2024-04-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 58,001,145 outstanding shares: 77% for, 4% against (80% of the company cast a for/against vote).

The 307 asset managers below cast 96% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 96%
FOR: 95.7%AGAINST: 4.3%ABSTAIN: 0.1%
Largest asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at INARI MEDICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard5,040,0120 00For
BlackRock5,037,934369 00For
Wellington3,899,9610 00For
AllianceBernstein2,773,9000 00For
HCC Manager LLC2,591,6650 00For
Hartford2,391,6770 00For
State Street1,881,5380 00For
BROWN ADVISORY INC1,559,1850 00For
JPMorgan1,492,4970 00For
Voya1,325,7470 00For
Fidelity1,257,7840 00For
GEODE CAPITAL MANAGEMENT, LLC1,168,4020 00For
American Century1,120,0710 00For
UBS01,048,067 00Against
Charles Schwab875,0880 00For
Franklin Templeton871,8470 00For
FIDUCIARY TRUST CO INTERNATIONAL753,1580 00For
Nuveen617,2130 00For
T. Rowe Price616,4650 00For
MUTUAL FUND SERIES TRUST575,9140 00For
TIAA573,7670 00For
BAMCO INC /NY/566,5030 00For
Allspring565,2380 00For
Brown Advisory Funds562,7150 00For
BOSTON MANAGEMENT & RESEARCH511,1160 00For

Showing the 25 largest of 307 asset managers. See all 307 in the interactive database.

2. To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Andrew Hykes

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%WITHHELD 20%
FOR: 37,514,003WITHHELD: 9,583,716

INARI MEDICAL INC.’s own tally for this item (“Elect Director: Andrew Hykes”): 37,514,003 for, 9,583,716 withheld, per its Form 8-K filed 2024-04-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 58,001,145 outstanding shares: 65% for, 17% withheld (81% of the company cast a for/withheld vote).

The 96 asset managers below cast 99.9% of the shares they voted on this item FOR (19,690,203 for, 69 against).

FOR 84%ABSTAIN 16%
FOR: 19,690,203 (84.2%)AGAINST: 69 (0.0%)ABSTAIN: 3,697,832 (15.8%)
Largest asset managers voting on “To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and unt” at INARI MEDICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,891,0030 00For
BlackRock3,161,1150 00For
Hartford2,391,6770 00For
Fidelity1,207,7460 00For
AllianceBernstein749,5860 00For
JPMorgan670,3920 00For
Voya591,4070 00For
MUTUAL FUND SERIES TRUST575,9140 00For
TIAA573,7670 00For
Brown Advisory Funds00 562,7150Abstain
American Century00 551,2550Abstain
AB DISCOVERY GROWTH FUND, INC.479,2480 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)466,0780 00For
FRANKLIN STRATEGIC SERIES452,1000 00For
Charles Schwab415,4610 00For
ALGER FUNDS00 408,8880Abstain
Principal170,3830 212,6970Abstain
Northwestern Mutual381,4050 00For
Equitable381,2480 00For
MFS00 321,1350Abstain
State Street309,4990 2510For
Brown Capital Management Mutual Funds273,9630 00For
T. Rowe Price272,1410 00For
Jackson National100,4250 148,8790Abstain
New York Life159,1710 89,3320For

Showing the 25 largest of 96 asset managers. See all 96 in the interactive database.

3. To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Donald Milder

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

73% Majority: yes · of votes cast

FOR 73%WITHHELD 27%
FOR: 34,564,964WITHHELD: 12,532,755

INARI MEDICAL INC.’s own tally for this item (“Elect Director: Donald Milder”): 34,564,964 for, 12,532,755 withheld, per its Form 8-K filed 2024-04-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 58,001,145 outstanding shares: 60% for, 22% withheld (81% of the company cast a for/withheld vote).

The 96 asset managers below cast 99.9% of the shares they voted on this item FOR (17,095,988 for, 69 against).

FOR 73%ABSTAIN 27%
FOR: 17,095,988 (73.1%)AGAINST: 69 (0.0%)ABSTAIN: 6,292,047 (26.9%)
Largest asset managers voting on “To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and unt” at INARI MEDICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,891,0030 00For
BlackRock3,161,1150 00For
Hartford2,391,6770 00For
Fidelity1,176,7760 30,9700For
AllianceBernstein00 749,5860Abstain
JPMorgan670,3920 00For
Voya00 591,4070Abstain
MUTUAL FUND SERIES TRUST575,9140 00For
TIAA573,7670 00For
Brown Advisory Funds00 562,7150Abstain
American Century00 551,2550Abstain
AB DISCOVERY GROWTH FUND, INC.00 479,2480Abstain
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)466,0780 00For
FRANKLIN STRATEGIC SERIES452,1000 00For
Charles Schwab415,4610 00For
ALGER FUNDS00 408,8880Abstain
Principal5760 382,5040Abstain
Northwestern Mutual381,4050 00For
Equitable103,0200 278,2280Abstain
MFS00 321,1350Abstain
State Street309,4990 2510For
Brown Capital Management Mutual Funds273,9630 00For
T. Rowe Price00 272,1410Abstain
Jackson National100,4250 148,8790Abstain
New York Life159,1710 89,3320For

Showing the 25 largest of 96 asset managers. See all 96 in the interactive database.

4. To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Rebecca Chambers

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD 21%
FOR: 37,413,521WITHHELD: 9,684,198

INARI MEDICAL INC.’s own tally for this item (“Elect Director: Rebecca Chambers”): 37,413,521 for, 9,684,198 withheld, per its Form 8-K filed 2024-04-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 58,001,145 outstanding shares: 65% for, 17% withheld (81% of the company cast a for/withheld vote).

The 96 asset managers below cast 99.9% of the shares they voted on this item FOR (19,395,385 for, 69 against).

FOR 83%ABSTAIN 17%
FOR: 19,395,385 (82.9%)AGAINST: 69 (0.0%)ABSTAIN: 3,992,650 (17.1%)
Largest asset managers voting on “To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and unt” at INARI MEDICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,891,0030 00For
BlackRock3,161,1150 00For
Hartford2,391,6770 00For
Fidelity1,207,7460 00For
AllianceBernstein749,5860 00For
JPMorgan670,3920 00For
Voya591,4070 00For
MUTUAL FUND SERIES TRUST575,9140 00For
TIAA573,7670 00For
Brown Advisory Funds00 562,7150Abstain
American Century00 551,2550Abstain
AB DISCOVERY GROWTH FUND, INC.479,2480 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)466,0780 00For
FRANKLIN STRATEGIC SERIES452,1000 00For
Charles Schwab415,4610 00For
ALGER FUNDS00 408,8880Abstain
Principal170,3830 212,6970Abstain
Northwestern Mutual381,4050 00For
Equitable381,2480 00For
MFS00 321,1350Abstain
State Street309,4990 2510For
Brown Capital Management Mutual Funds273,9630 00For
T. Rowe Price00 272,1410Abstain
Jackson National100,4250 148,8790Abstain
New York Life159,1710 89,3320For

Showing the 25 largest of 96 asset managers. See all 96 in the interactive database.

5. To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: William Hoffman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

72% Majority: yes · of votes cast

FOR 72%WITHHELD 28%
FOR: 33,808,366WITHHELD: 12,904,066

INARI MEDICAL INC.’s own tally for this item (“Elect Director: William Hoffman”): 33,808,366 for, 12,904,066 withheld, per its Form 8-K filed 2024-04-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 58,001,145 outstanding shares: 58% for, 22% withheld (81% of the company cast a for/withheld vote).

The 96 asset managers below cast 99.9% of the shares they voted on this item FOR (17,314,660 for, 69 against).

FOR 74%ABSTAIN 26%
FOR: 17,314,660 (74.0%)AGAINST: 69 (0.0%)ABSTAIN: 6,073,375 (26.0%)
Largest asset managers voting on “To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and unt” at INARI MEDICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,891,0030 00For
BlackRock3,161,1150 00For
Hartford2,391,6770 00For
Fidelity1,176,7760 30,9700For
AllianceBernstein00 749,5860Abstain
JPMorgan670,3920 00For
Voya591,4070 00For
MUTUAL FUND SERIES TRUST575,9140 00For
TIAA573,7670 00For
Brown Advisory Funds00 562,7150Abstain
American Century00 551,2550Abstain
AB DISCOVERY GROWTH FUND, INC.00 479,2480Abstain
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)466,0780 00For
FRANKLIN STRATEGIC SERIES452,1000 00For
Charles Schwab415,4610 00For
ALGER FUNDS00 408,8880Abstain
Principal5760 382,5040Abstain
Northwestern Mutual381,4050 00For
Equitable103,0200 278,2280Abstain
MFS00 321,1350Abstain
State Street1180 309,6320Abstain
Brown Capital Management Mutual Funds273,9630 00For
T. Rowe Price00 272,1410Abstain
Jackson National100,4250 148,8790Abstain
New York Life159,1710 89,3320For

Showing the 25 largest of 96 asset managers. See all 96 in the interactive database.

6. To ratify the appointment of BDO USA, P.C. as the independent registered public accounting firm for the Company's fiscal year ending December 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 53,055,768AGAINST: 38,761

INARI MEDICAL INC.’s own tally for this item (“Proposal 2: The stockholders ratified the selection of BDO USA, PC as the Company's independent registered public accounting firm for the year ending December 31, 2024.”): 53,055,768 for, 38,761 against, per its Form 8-K filed 2024-04-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 58,001,145 outstanding shares: 91% for, 0.1% against (92% of the company cast a for/against vote).

The 96 asset managers below cast 99.9% of the shares they voted on this item FOR (23,352,567 for, 151 against).

FOR 99.8%
FOR: 23,352,567 (99.8%)AGAINST: 151 (0.0%)ABSTAIN: 35,386 (0.2%)
Largest asset managers voting on “To ratify the appointment of BDO USA, P.C. as the independent registered public accounting firm for the Compan” at INARI MEDICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,891,0030 00For
BlackRock3,161,1150 00For
Hartford2,391,6770 00For
Fidelity1,207,7460 00For
AllianceBernstein749,5860 00For
JPMorgan670,3920 00For
Voya591,4070 00For
MUTUAL FUND SERIES TRUST575,9140 00For
TIAA573,7670 00For
Brown Advisory Funds562,7150 00For
American Century551,2550 00For
AB DISCOVERY GROWTH FUND, INC.479,2480 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)466,0780 00For
FRANKLIN STRATEGIC SERIES452,1000 00For
Charles Schwab415,4610 00For
ALGER FUNDS408,8880 00For
Principal383,0800 00For
Northwestern Mutual381,4050 00For
Equitable381,2480 00For
MFS321,1350 00For
State Street309,7500 00For
Brown Capital Management Mutual Funds273,9630 00For
T. Rowe Price272,1410 00For
Jackson National249,3040 00For
New York Life248,5030 00For

Showing the 25 largest of 96 asset managers. See all 96 in the interactive database.

Largest INARI MEDICAL INC. shareholders voting in 2023-2024

Ranked by the number of INARI MEDICAL INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 58,001,145 shares outstanding at the time of that meeting.

Top INARI MEDICAL INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 8.69%
2BlackRock 8.69%
3Wellington 6.72%
4AllianceBernstein 4.78%
5HCC Manager LLC 4.47%
6Hartford 4.12%
7State Street 3.24%
8BROWN ADVISORY INC 2.69%
9JPMorgan 2.57%
10Voya 2.29%

Reported INARI MEDICAL INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

INARI MEDICAL INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock, Inc. 11.55% DEF14A
The Vanguard Group 8.69% 13G
Donald Milder 5.32% DEF14A
Franklin Templeton 4.44% 13F
State Street 3.56% 13F
Norges Bank 2.26% 13F
Wellington Management 2.15% 13F
Geode Capital 2.04% 13F
William Hoffman 1.75% DEF14A
Dimensional Fund Advisors 1.23% 13F

Percentages above are of 58,001,145 shares outstanding, as reported by INARI MEDICAL INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from INARI MEDICAL INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At INARI MEDICAL INC.'s shareholder meeting held 2024-04-24, in the 2023-2024 proxy season, 309 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 2,573 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: INARI MEDICAL INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-04-25.

INARI MEDICAL INC. proxy season coverage: 2023-2024 (this page).